William Bertrand - Chief Operating Officer at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
ADAP on Nasdaq
All Insider Reports
All Insider Reports

William Bertrand - trading volume in the past year for Adaptimmune Therapeutics PLC

Holdings reported by William Bertrand for Adaptimmune Therapeutics PLC

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 20.2K $13.6K $0.67 Jan 17, 2024 Direct
Option to purchase Ordinary Shares 565K Jan 15, 2024 Direct Ordinary Shares

Transactions reported by William Bertrand for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.